In vitro growth activity of novel purine- and pyrimidine-based CDK1 and CDK2 inhibitors.

被引：0
|
作者：
Arris, CE
Boyle, FT
Calvert, AH
Curtin, NJ
Dewsbury, PJ
Endicott, JA
Gibson, AE
Golding, BT
Grant, S
Griffin, RJ
Johnson, LN
Noble, MEM
Newell, DR
Sausville, E
Schultz, R
机构：
[1] Univ Newcastle Upon Tyne, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England
[2] Univ Oxford, Oxford OX1 3QU, England
[3] NCI, DTP, Washington, DC USA
[4] Zeneca Pharmaceut, Macclesfield SK10 4TG, Cheshire, England
来源：
BRITISH JOURNAL OF CANCER | 1999年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
110
引用
收藏
页码：11 / 11
页数：1
相关论文
共 50 条
  • [21] CDK2 and CDK1 specific activities: A novel prognostic indicator in early breast cancer
    Kim, S.
    Masuda, N.
    Inaji, H.
    Yoshidome, K.
    Tsujimoto, M.
    Akiyama, F.
    Ishihara, H.
    Hortobagyi, G. N.
    Ueno, N. T.
    Noguchi, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [22] Molecular Modeling and Design Studies of Purine Derivatives as Novel CDK2 Inhibitors
    Zhang, Gaomin
    Ren, Yujie
    MOLECULES, 2018, 23 (11):
  • [23] Increased activity of both CDK1 and CDK2 is necessary for the combinatorial activity of WEE1 inhibition and cytarabine
    Garcia, Tamara B.
    Fosmire, Susan P.
    Porter, Christopher C.
    LEUKEMIA RESEARCH, 2018, 64 : 30 - 33
  • [24] Design, synthesis, and biological evaluation of novel pyrimidine derivatives as CDK2 inhibitors
    Ibrahim, Diaa A.
    El-Metwally, Amira M.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2010, 45 (03) : 1158 - 1166
  • [25] The Cdk1/Cdk2 homolog CDKA;1 controls the recombination landscape in Arabidopsis
    Wijnker, Erik
    Harashima, Hirofumi
    Mueller, Katja
    Parra-Nunez, Pablo
    Bastiaan de Snoo, C.
    van de Belt, Jose
    Dissmeyer, Nico
    Bayer, Martin
    Pradillo, Monica
    Schnittger, Arp
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2019, 116 (25) : 12534 - 12539
  • [26] A convenient synthesis and molecular modeling study of novel purine and pyrimidine derivatives as CDK2/cyclin A3 inhibitors
    Elgazwy, Abdel-Sattar S. Hamad
    Ismail, Nasser S. M.
    Elzahabi, Heba S. A.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2010, 18 (21) : 7639 - 7650
  • [27] Cdk1, but not Cdk2, is the sole Cdk that is essential and sufficient to drive resumption of meiosis in mouse oocytes
    Adhikari, Deepak
    Zheng, Wenjing
    Shen, Yan
    Gorre, Nagaraju
    Ning, Yao
    Halet, Guillaume
    Kaldis, Philipp
    Liu, Kui
    HUMAN MOLECULAR GENETICS, 2012, 21 (11) : 2476 - 2484
  • [28] In Silico Drug Design: Development of New Pyrimidine-based Benzothiazole Derivatives, Selective for CDK2
    Kasmi, Rania
    Elmchichi, Larbi
    El Aissouq, Abdellah
    Bouachrine, Mohammed
    Ouammou, Abdelkrim
    LETTERS IN DRUG DESIGN & DISCOVERY, 2021, 18 (10) : 961 - 975
  • [29] Understanding biological rationale for specific activity of CDK1 and CDK2 as a prognostic marker of breast cancer recurrence
    Shibayama, Masaki
    Numada, Shigehiro
    Matsushima, Tomoko
    Nakayama, Satoshi
    Kiniwa, Tadashi
    Harada, Amane
    Kim, Seung
    Shimomura, Atsushi
    Noguchi, Shinzaburo
    Ishihara, Hideki
    CANCER RESEARCH, 2009, 69
  • [30] CDK1 and CDK2 regulate NICD1 turnover and the periodicity of the segmentation clock
    Carrieri, Francesca Anna
    Murray, Philip J.
    Ditsova, Dimitrinka
    Ferris, Margaret Ashley
    Davies, Paul
    Dale, Jacqueline Kim
    EMBO REPORTS, 2019, 20 (07)
12345